From hormone balance and mitochondrial repair to inflammation control and interventional longevity, this conversation unpacks how peptide therapy is reshaping the future of aging
Analysis of more recent pharmaceutical dispensing data show that in 2024, approximately 160,000 patients in New Zealand were dispensed a urate-lowering medicine, most often allopurinol (141 patients per 1,000 registered patients
Product Overview BPC-157 / TB-500 combines two extensively studied peptide compounds within a single research preparation designed for controlled laboratory investigations involving peptide signalling systems, molecular communication pathways and peptide interaction models
What these percentages mean for real people Let us make this concrete
By facilitating the healing of gastric and intestinal tissues and mitigating the detrimental effects of these medications, BPC-157 suggests a promising synergy when used alongside NSAIDs
Peptides are supportive tools, not guaranteed cures